Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q2 2024 Earnings

14MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-0.16

-0.12

-0.07

-0.03

Details

Expected EPS

-0.07

Actual EPS

-0.05

Surprise EPS

0.02

Surprise Percent

+28.57%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.05 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.